Application Sponsors
ANDA 207181 | DEVA HOLDING AS | |
Marketing Status
Application Products
001 | INJECTABLE;INTRAVENOUS | EQ 40MG BASE/VIAL | 0 | ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE SODIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2017-03-06 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
DEVA HOLDING AS
cder:Array
(
[0] => Array
(
[ApplNo] => 207181
[companyName] => DEVA HOLDING AS
[docInserts] => ["",""]
[products] => [{"drugName":"ESOMEPRAZOLE SODIUM","activeIngredients":"ESOMEPRAZOLE SODIUM","strength":"EQ 40MG BASE\/VIAL","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"03\/06\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2017-03-06
)
)